(Q37643057)

21 August 2017

1 reference

title

Invasive fungal infections in the ICU. (English)

1 reference

invasive fungal infections

21 August 2017

main subject

1 reference

Shmuel Shoham

1

1 reference

21 August 2017

Shilpa Marwaha

series ordinal

2

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Journal of Intensive Care Medicine

21 August 2017

published in

1 reference

21 August 2017

volume

25

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

78-92

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Use of multilocus sequence typing for the investigation of colonisation by Candida albicans in intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candida spp. colonization significance in critically ill medical patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Nosocomial aspergillosis in outbreak settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Revisiting the Source of Candidemia: Skin or Gut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Mucosal damage and neutropenia are required for Candida albicans dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The immune response to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Association between blood glucose levels and development of candidemia in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Acquired disorders of phagocyte function complicating medical and surgical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Impaired function of macrophage Fc gamma receptors in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Altered monocyte function in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Antimicrobial peptides from human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Th17 cells: a new fate for differentiating helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Association of fluconazole pharmacodynamics with mortality in patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Population pharmacokinetics of fluconazole in young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Oral azole drugs as systemic antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Antifungal use in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

21 January 2018

Antifungals in the ICU.

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Evaluation of voriconazole pharmacodynamics using time-kill methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Hallucinations during voriconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Changing epidemiology of invasive candidiasis in intensive care units--much ado about nothing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Spectrophotometric analysis of organisation of dipalmitoylphosphatidylcholine bilayers containing the polyene antibiotic amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Antifungal pharmacodynamics: concentration-effect relationships in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Pharmacokinetics of amphotericin B in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Attributable mortality of nosocomial candidemia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candida albicans outbreak in a neurosurgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Endogenous Candida endophthalmitis after intravenous anesthesia with propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Postoperative infections traced to contamination of an intravenous anesthetic, propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemic bloodstream infections associated with pressure transducers: a persistent problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemiological trends in nosocomial candidemia in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Immunoparalysis as a cause for invasive aspergillosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Disseminated aspergillosis in intensive care unit patients: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Invasive pulmonary aspergillosis after near-drowning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Invasive pulmonary and central nervous system aspergillosis after near-drowning of a child: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Invasive aspergillosis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Zygomycosis (mucormycosis): emerging clinical importance and new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Zygomycosis: the re-emerging fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Zygomycosis in children: a systematic review and analysis of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

B7/CD28-Dependent CD4+CD25+ Regulatory T Cells Are Essential Components of the Memory-Protective Immunity to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Candidemia in intensive care unit patients: Risk factors for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

Voriconazole Prophylaxis in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066609355262

21 January 2018

Identifiers

DOI

10.1177/0885066609355262

1 reference

21 August 2017

1 reference